HighPoint Advisor Group’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-907	Closed	-$222K	–	708
2024 Q2	$222K	Sell	907 -47	-5%	-$10.7K	0.01%	556
2024 Q1	$218K	Sell	954 -18	-2%	-$4.3K	0.02%	579
2023 Q4	$258K	Buy	+972	New	+$191K	0.02%	514
2022 Q2	$320K	Buy	+1,416	New	+$346K	0.04%	386
2021 Q3	$955K	Buy	2,314 +87	+4%	+$36.1K	0.09%	177
2021 Q2	$824K	Buy	2,227 +67	+3%	+$22.4K	0.08%	203
2021 Q1	$662K	Sell	2,160 -156	-7%	-$43.4K	0.08%	214
2020 Q4	$644K	Buy	2,316 +1,015	+78%	+$242K	0.08%	204
2020 Q3	$327K	Sell	1,301 -409	-24%	-$84.9K	0.06%	256
2020 Q2	$300K	Sell	1,710 -254	-13%	-$40.5K	0.06%	244
2020 Q1	$268K	Buy	+1,964	New	+$295K	0.06%	232
2019 Q4	–	Sell	-887	Closed	-$115K	–	392
2019 Q3	$115K	Buy	887 +104	+13%	+$13.9K	0.03%	438
2019 Q2	$106K	Buy	+783	New	+$106K	0.02%	443
2017 Q4	–	Sell	-8,056	Closed	-$944K	–	302
2017 Q3	$944K	Buy	8,056 +2,643	+49%	+$272K	0.29%	87
2017 Q2	$539K	Hold	5,413	–	–	0.17%	148
2017 Q1	$539K	Buy	+5,413	New	+$460K	0.17%	148